Literature DB >> 25355742

Transorbital superior ophthalmic vein sacrifice to preserve vision in ocular hypertension from aseptic cavernous sinus thrombosis.

Travis R Ladner1, Brandon J Davis1, Lucy He1, Louise A Mawn2, J Mocco1.   

Abstract

Aseptic cavernous sinus thrombosis (CST) is rare and may clinically masquerade as a carotid cavernous fistula. Conventional management includes oral anticoagulation, but cases of ocular hypertension affecting vision may require more aggressive intervention. We report a case of a woman with spontaneous bilaterally occluded cavernous sinuses with elevated intraocular pressure (IOP), which resolved immediately following unilateral superior ophthalmic vein (SOV) sacrifice. She was subsequently placed on oral anticoagulants. By 4 months postoperatively her IOP was normalized and her vision had improved. Repeat angiography demonstrated stable venous filling, with some mild improvement of flow through the cavernous sinus. Coil-mediated sacrifice of the SOV might be an effective means to relieve ocular hypertension and preserve vision in the setting of aseptic CST. 2014 BMJ Publishing Group Ltd.

Entities:  

Keywords:  Blood Flow; Coil; Intervention; Orbit; Vein

Mesh:

Year:  2014        PMID: 25355742      PMCID: PMC4216906          DOI: 10.1136/bcr-2014-011454

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  15 in total

1.  Targeted compartmental embolization of cavernous sinus dural arteriovenous fistulae using transfemoral medial and lateral facial vein approaches.

Authors:  R Agid; R A Willinsky; C Haw; M P S Souza; I J Vanek; K G terBrugge
Journal:  Neuroradiology       Date:  2003-12-04       Impact factor: 2.804

Review 2.  Cavernous sinus thrombosis: current therapy.

Authors:  Valmont Desa; Ryan Green
Journal:  J Oral Maxillofac Surg       Date:  2012-02-09       Impact factor: 1.895

3.  Sudden onset proptosis secondary to cavernous sinus thrombosis from underlying mandibular dental infection.

Authors:  Robin Gwynne Jones; Brendan Arnold
Journal:  BMJ Case Rep       Date:  2009-07-26

4.  Cavernous-dural fistula with secondary angle-closure glaucoma.

Authors:  S J Talks; J F Salmon; J S Elston; A J Bron
Journal:  Am J Ophthalmol       Date:  1997-12       Impact factor: 5.258

5.  Ocular manifestations of cavernous sinus thrombosis.

Authors:  V Visvanathan; S Uppal; S Prowse
Journal:  BMJ Case Rep       Date:  2010-12-03

6.  Spontaneous superior ophthalmic vein thrombosis: a rare entity with potentially devastating consequences.

Authors:  L H Lim; R L Scawn; K M Whipple; S R Oh; M J Lucarelli; B S Korn; D O Kikkawa
Journal:  Eye (Lond)       Date:  2013-12-20       Impact factor: 3.775

7.  Endovascular approach and technique for treatment of transverse-sigmoid dural arteriovenous fistula with cortical reflux: the importance of venous sinus sacrifice.

Authors:  Andrew Phillip Carlson; Ali Alaraj; Sepideh Amin-Hanjani; Fady T Charbel; Victor Aletich
Journal:  J Neurointerv Surg       Date:  2012-10-10       Impact factor: 5.836

8.  EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients.

Authors:  K Einhäupl; J Stam; M-G Bousser; S F T M De Bruijn; J M Ferro; I Martinelli; F Masuhr
Journal:  Eur J Neurol       Date:  2010-10       Impact factor: 6.089

9.  Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis.

Authors:  S F de Bruijn; J Stam
Journal:  Stroke       Date:  1999-03       Impact factor: 7.914

10.  Cerebral venous thrombosis: combined intrathrombus rtPA and intravenous heparin.

Authors:  J L Frey; G J Muro; C G McDougall; B L Dean; H K Jahnke
Journal:  Stroke       Date:  1999-03       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.